Orasure Technologies (OSUR) 6.92 $OSUR
Analyst Bullish On Medical Research, Equipment Stocks
at Investor's Business Daily - Tue Apr 08, 12:33PM CDT
A new analyst report from Cowen & Co. offers an upbeat assessment of medical research and equipment stocks ahead of first-quarter earnings, thanks to improving end markets. In his report on the Life Sciences and Diagnostic Tools sectors on Tuesday,...
OraSure Technologies Up 15.5% Since SmarTrend Uptrend Call (OSUR)
Comtex SmarTrend(R) - Fri Apr 04, 9:33AM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 18th, 2014 at $6.74. In approximately 2 month, OraSure Technologies has returned 15.52% as of today's recent price of $7.78.
OraSure Technologies' Debra Fraser-Howze Receives 2014 "Top Blacks in Healthcare" Award
GlobeNewswire - Fri Apr 04, 5:27AM CDT
OraSure Technologies, Inc. (Nasdaq:OSUR) is proud to announce that Debra Fraser-Howze, the Company's Senior Vice President of Government and External Affairs, received a 2014 "Top Blacks in Healthcare" Award from BlackDoctor.org in partnership with Johns Hopkins Center for Health Disparities Solutions.
4 Stocks Under $10 Moving Higher
at The Street - Fri Mar 28, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
OraSure Technologies Up 21.2% Since SmarTrend Uptrend Call (OSUR)
Comtex SmarTrend(R) - Thu Mar 27, 5:16PM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 18th, 2014 at $6.74. In approximately 1 month, OraSure Technologies has returned 21.16% as of today's recent price of $8.16.
SQI Diagnostics Signs Commercial Agreement with Global Pharma Customer
PR Newswire - Thu Mar 20, 2:26PM CDT
SQI to Develop Custom 21-Plex Protein Microarray for Drug Epitope Mapping -
OraSure Technologies Shares Up 18.6% Since SmarTrend's Buy Recommendation (OSUR)
Comtex SmarTrend(R) - Thu Mar 20, 11:13AM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 18th, 2014 at $6.74. In approximately 1 month, OraSure Technologies has returned 18.63% as of today's recent price of $7.99.
Uptrend Call Working As OraSure Technologies Stock Rises 19.2% (OSUR)
Comtex SmarTrend(R) - Thu Mar 13, 10:05AM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 18th, 2014 at $6.74. In approximately 3 weeks, OraSure Technologies has returned 19.23% as of today's recent price of $8.03.
Regulatory Approvals, Pricing of Public Offering, Stock Price Movements, and Financial Reports - Analyst Notes on Arrowhead, ANI, OraSure, Rigel, and Foundation Medicine
PR Newswire - Mon Mar 10, 11:30AM CDT
Today, Analysts Review released its analysts' notes regarding Arrowhead Research Corp. (NASDAQ: ARWR), ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), OraSure Technologies, Inc. (NASDAQ: OSUR), Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), and Foundation Medicine, Inc. (NASDAQ: FMI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
3 Ways You Can Be a Better Health-Care Investor Than Warren Buffett
Sean Williams, The Motley Fool - Motley Fool - Sun Mar 09, 1:03PM CDT
Behind only three other people on this planet -- Bill Gates, Carlos Slim, and Amancio Ortega -- stands Warren Buffett with $58.2 billion in accumulated wealth, according to Forbes ' latest rankings of the world's richest people. Buffett, perhaps...
Why OraSure Technologies, Inc. Shares Jumped
Sean Williams, The Motley Fool - Motley Fool - Wed Mar 05, 4:07PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of OraSure Technologies , a marketer of...
OraSure Technologies to Present at the Cowen & Company 34th Annual Health Care Conference
GlobeNewswire - Wed Feb 26, 5:00AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Cowen & Co. 34 Annual Health Care Conference in Boston, Massachusetts. The conference will be simultaneously webcast over the Internet.
OraSure Technologies to Present at the Raymond James 35th Annual Institutional Investors Conference
GlobeNewswire - Mon Feb 24, 5:12AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Raymond James 35 Annual Institutional Investors Conference in Orlando, Florida. The conference will be simultaneously webcast over the Internet.
Fusion Antibodies Announces Collaboration with Pepscan to offer Precision Epitope Mapping
PRWeb - Mon Feb 24, 2:08AM CST
UK based contract research organisation Fusion Antibodies and Dutch based biotechnology company Pepscan, a leading provider of epitope mapping services, have today announced a partnership to offer Pepscan's Precision Epitope Mapping platform to Fusion Antibodies clients. The partnership will have great benefits for Fusion Antibodies clients as it will offer them an integrated end-to-end solution for the pre-clinical development of antibodies. Fusion Antibodies can now not only provide Antibody Engineering, Humanization and development of high yielding stable cell lines but a range of high quality characterisation studies through their expert partners.
OraSure Technologies to Present at the 2014 Citi Global Healthcare Conference
GlobeNewswire - Thu Feb 20, 5:00AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 2014 Citi Global Healthcare Conference in New York City. The conference will be simultaneously webcast over the Internet.
OraSure Technologies (OSUR) Jumps: Stock Up 10.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 7:51AM CST
OraSure Technologies, Inc. was a big mover last session, as its shares rose over 10% on the day.
Biotech Winners: Pernix, Myriad, Repros, OraSure
David Williamson and Max Macaluso, The Motley Fool - Motley Fool - Thu Feb 06, 7:40PM CST
In this video from Thursday's Market Checkup , Motley Fool health-care analysts David Williamson and Max Macaluso dive into the biggest stories impacting health-care investors on the market today. In this segment, a look at some big winners during...
Why OraSure Technologies, Inc. Shares Popped
Alex Planes, The Motley Fool - Motley Fool - Thu Feb 06, 12:11PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of OraSure Technologies, have gained 10%...
Analyst Bullish On Medical Research, Equipment Stocks
at Investor's Business Daily - Tue Apr 08, 12:33PM CDT
A new analyst report from Cowen & Co. offers an upbeat assessment of medical research and equipment stocks ahead of first-quarter earnings, thanks to improving end markets. In his report on the Life Sciences and Diagnostic Tools sectors on Tuesday,...
OraSure Technologies Up 15.5% Since SmarTrend Uptrend Call (OSUR)
Comtex SmarTrend(R) - Fri Apr 04, 9:33AM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 18th, 2014 at $6.74. In approximately 2 month, OraSure Technologies has returned 15.52% as of today's recent price of $7.78.
OraSure Technologies' Debra Fraser-Howze Receives 2014 "Top Blacks in Healthcare" Award
GlobeNewswire - Fri Apr 04, 5:27AM CDT
OraSure Technologies, Inc. (Nasdaq:OSUR) is proud to announce that Debra Fraser-Howze, the Company's Senior Vice President of Government and External Affairs, received a 2014 "Top Blacks in Healthcare" Award from BlackDoctor.org in partnership with Johns Hopkins Center for Health Disparities Solutions.
4 Stocks Under $10 Moving Higher
at The Street - Fri Mar 28, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
OraSure Technologies Up 21.2% Since SmarTrend Uptrend Call (OSUR)
Comtex SmarTrend(R) - Thu Mar 27, 5:16PM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 18th, 2014 at $6.74. In approximately 1 month, OraSure Technologies has returned 21.16% as of today's recent price of $8.16.
SQI Diagnostics Signs Commercial Agreement with Global Pharma Customer
PR Newswire - Thu Mar 20, 2:26PM CDT
SQI to Develop Custom 21-Plex Protein Microarray for Drug Epitope Mapping -
OraSure Technologies Shares Up 18.6% Since SmarTrend's Buy Recommendation (OSUR)
Comtex SmarTrend(R) - Thu Mar 20, 11:13AM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 18th, 2014 at $6.74. In approximately 1 month, OraSure Technologies has returned 18.63% as of today's recent price of $7.99.
Uptrend Call Working As OraSure Technologies Stock Rises 19.2% (OSUR)
Comtex SmarTrend(R) - Thu Mar 13, 10:05AM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 18th, 2014 at $6.74. In approximately 3 weeks, OraSure Technologies has returned 19.23% as of today's recent price of $8.03.
Regulatory Approvals, Pricing of Public Offering, Stock Price Movements, and Financial Reports - Analyst Notes on Arrowhead, ANI, OraSure, Rigel, and Foundation Medicine
PR Newswire - Mon Mar 10, 11:30AM CDT
Today, Analysts Review released its analysts' notes regarding Arrowhead Research Corp. (NASDAQ: ARWR), ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), OraSure Technologies, Inc. (NASDAQ: OSUR), Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), and Foundation Medicine, Inc. (NASDAQ: FMI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
3 Ways You Can Be a Better Health-Care Investor Than Warren Buffett
Sean Williams, The Motley Fool - Motley Fool - Sun Mar 09, 1:03PM CDT
Behind only three other people on this planet -- Bill Gates, Carlos Slim, and Amancio Ortega -- stands Warren Buffett with $58.2 billion in accumulated wealth, according to Forbes ' latest rankings of the world's richest people. Buffett, perhaps...
Why OraSure Technologies, Inc. Shares Jumped
Sean Williams, The Motley Fool - Motley Fool - Wed Mar 05, 4:07PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of OraSure Technologies , a marketer of...
OraSure Technologies to Present at the Cowen & Company 34th Annual Health Care Conference
GlobeNewswire - Wed Feb 26, 5:00AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Cowen & Co. 34 Annual Health Care Conference in Boston, Massachusetts. The conference will be simultaneously webcast over the Internet.
OraSure Technologies to Present at the Raymond James 35th Annual Institutional Investors Conference
GlobeNewswire - Mon Feb 24, 5:12AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Raymond James 35 Annual Institutional Investors Conference in Orlando, Florida. The conference will be simultaneously webcast over the Internet.
Fusion Antibodies Announces Collaboration with Pepscan to offer Precision Epitope Mapping
PRWeb - Mon Feb 24, 2:08AM CST
UK based contract research organisation Fusion Antibodies and Dutch based biotechnology company Pepscan, a leading provider of epitope mapping services, have today announced a partnership to offer Pepscan's Precision Epitope Mapping platform to Fusion Antibodies clients. The partnership will have great benefits for Fusion Antibodies clients as it will offer them an integrated end-to-end solution for the pre-clinical development of antibodies. Fusion Antibodies can now not only provide Antibody Engineering, Humanization and development of high yielding stable cell lines but a range of high quality characterisation studies through their expert partners.
OraSure Technologies to Present at the 2014 Citi Global Healthcare Conference
GlobeNewswire - Thu Feb 20, 5:00AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 2014 Citi Global Healthcare Conference in New York City. The conference will be simultaneously webcast over the Internet.
OraSure Technologies (OSUR) Jumps: Stock Up 10.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 7:51AM CST
OraSure Technologies, Inc. was a big mover last session, as its shares rose over 10% on the day.
Biotech Winners: Pernix, Myriad, Repros, OraSure
David Williamson and Max Macaluso, The Motley Fool - Motley Fool - Thu Feb 06, 7:40PM CST
In this video from Thursday's Market Checkup , Motley Fool health-care analysts David Williamson and Max Macaluso dive into the biggest stories impacting health-care investors on the market today. In this segment, a look at some big winners during...
Why OraSure Technologies, Inc. Shares Popped
Alex Planes, The Motley Fool - Motley Fool - Thu Feb 06, 12:11PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of OraSure Technologies, have gained 10%...
